MedPlus Health Services Ltd banner

MedPlus Health Services Ltd
NSE:MEDPLUS

Watchlist Manager
MedPlus Health Services Ltd Logo
MedPlus Health Services Ltd
NSE:MEDPLUS
Watchlist
Price: 838.2 INR -0.74% Market Closed
Market Cap: ₹100.7B

Wall St Price Targets

MEDPLUS Price Targets Summary
MedPlus Health Services Ltd

Wall Street analysts forecast MEDPLUS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDPLUS is 1 192.09 INR with a low forecast of 1 111 INR and a high forecast of 1 334.55 INR.

Lowest Forecast
Price Target
1 111 INR
33% Upside
Average Forecast
Price Target
1 192.09 INR
42% Upside
Highest Forecast
Price Target
1 334.55 INR
59% Upside
MedPlus Health Services Ltd Competitors:
Price Targets

Revenue
Forecast

16% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
16% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 5 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 4 years is 15%.

Gross Profit
Forecast

23% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
23% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 5 years, the compound annual growth rate for Gross Profit has been 23%. The projected CAGR for the next 4 years is 18%.

Operating Income
Forecast

21% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
21% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 5 years, the compound annual growth rate for Operating Income has been 21%. The projected CAGR for the next 4 years is 22%.

Pre-Tax Income
Forecast

44% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
44% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 5 years, the compound annual growth rate for Pre-Tax Income has been 44%. The projected CAGR for the next 3 years is 25%.

Net Income
Forecast

133% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat
133% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat

Over the last 5 years, the compound annual growth rate for Net Income has been 133%. The projected CAGR for the next 4 years is 22%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MEDPLUS's stock price target?
Price Target
1 192.09 INR

According to Wall Street analysts, the average 1-year price target for MEDPLUS is 1 192.09 INR with a low forecast of 1 111 INR and a high forecast of 1 334.55 INR.

What is the Revenue forecast for MedPlus Health Services Ltd?
Projected CAGR
15%

Over the last 5 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 4 years is 15%.

What is the Gross Profit forecast for MedPlus Health Services Ltd?
Projected CAGR
18%

Over the last 5 years, the compound annual growth rate for Gross Profit has been 23%. The projected CAGR for the next 4 years is 18%.

What is the Operating Income forecast for MedPlus Health Services Ltd?
Projected CAGR
22%

Over the last 5 years, the compound annual growth rate for Operating Income has been 21%. The projected CAGR for the next 4 years is 22%.

What is the Pre-Tax Income forecast for MedPlus Health Services Ltd?
Projected CAGR
25%

Over the last 5 years, the compound annual growth rate for Pre-Tax Income has been 44%. The projected CAGR for the next 3 years is 25%.

What is the Net Income forecast for MedPlus Health Services Ltd?
Projected CAGR
22%

Over the last 5 years, the compound annual growth rate for Net Income has been 133%. The projected CAGR for the next 4 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett